The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
 
 
 
 

Hemodynamic effects of nitroprusside in infants with a large ventricular septal defect.

To evaluate the effect of acute vasodilator therapy, nitroprusside was administered at cardiac catheterization to five infants (ages 10 days to 6 months) with isolated ventricular septal defect and congestive heart failure. Intravenous nitroprusside was begun at a dose of 0.5 micrograms/kg/min and was increased by increments of 0.5 micrograms/kg. Hemodynamic measurements were made before nitroprusside, after 5 minutes at each dose, and 10 minutes after nitroprusside was discontinued. Baseline data were obtained before nitroprusside administration and compared with data obtained at maximal nitroprusside dose. The pulmonary-to-systemic flow ratio increased from 2.2 +/- 0.2 to 3.4 +/- 0.2 (mean +/- SEM, p less than 0.05) as a consequence of a marked decrease in systemic blood flow (5.3 +/- 0.7 to 3.6 +/- 0.51/min/m(2), p less than 0.05). Pulmonary flow did not change significantly. Mean pulmonary capillary wedge and right atrial pressures decreased by 53% (10.2 +/- 1.4 to 4.8 +/- 1.4 mm Hg [p less than 0.01] and 6.0 +/- 1.4 to 2.8 +/- 1.1 mm Hg [p less than 0.05], respectively). Decreases in mean aortic (63.6 +/- 3.0 to 54.6 +/- 2.1 mm Hg, p less than 0.05) and mean pulmonary artery pressure (41.4 +/- 6.2 to 32.0 +/- 6.7 mm Hg, p less than 0.05) were also observed. An apparently paradoxical increase in systemic resistance occurred (11.7 +/- 1.6 to 15.4 +/- 2.4 U, p less than 0.05. Our data show that nitroprusside causes a marked decrease in systemic blood flow and an increase in the pulmonary-to-systemic flow ratio in infants with a large ventricular septal defect. These findings may be related to the hemodynamic profile of these infants, in whom ventricular function, cardiac output and systemic resistance are normal.[1]

References

  1. Hemodynamic effects of nitroprusside in infants with a large ventricular septal defect. Beekman, R.H., Rocchini, A.P., Rosenthal, A. Circulation (1981) [Pubmed]
 
WikiGenes - Universities